AdaptHealth Corp. to Participate in Upcoming Investor Conference
About AdaptHealth Corp.
AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including CPAP and BiLevel services) to individuals for the treatment of obstructive sleep apnea. The Respiratory Health segment provides oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services to individuals for the treatment of respiratory diseases, such as chronic obstructive pulmonary disease and chronic respiratory failure. The Diabetes Health segment provides medical devices, including continuous glucose monitors and insulin pumps, and related services to patients for the treatment of diabetes. The Wellness at Home segment provides home medical equipment and services to patients in their homes including those who have been discharged from acute care and other facilities. The segment tailors a service model to patients who are adjusting to new lifestyles or navigating complex disease states by providing essential medical supplies and durable medical equipment.
The Company is proud to partner with an extensive and highly diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid, and commercial insurance payors, reaching approximately 4.2 million patients annually in all 50 states through its network of approximately 660 locations in 47 states.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Bentley Earnings: What To Look For From BSY
Infrastructure design software provider Bentley Systems (NASDAQ:BSY) will be reporting results this Wednesday morning. Here's what investors should know. Bentley beat analysts' revenue expectations by 1.4% last quarter, reporting revenues of $370.5 million, up 9.7% year on year. It was a very strong quarter for the company, with a solid beat of analysts' EBITDA estimates and an impressive beat of analysts' billings estimates. Is Bentley a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Bentley's revenue to grow 10% year on year to $363.4 million, slowing from the 11.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.29 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Bentley has missed Wall Street's revenue estimates four times over the last two years. Looking at Bentley's peers in the software-as-a-service segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Manhattan Associates delivered year-on-year revenue growth of 2.7%, beating analysts' expectations by 3.3%, and Palantir reported revenues up 48%, topping estimates by 6.8%. Manhattan Associates traded up 7% following the results. Read our full analysis of Manhattan Associates's results here and Palantir's results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the software-as-a-service stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3% on average over the last month. Bentley is up 4.3% during the same time and is heading into earnings with an average analyst price target of $54.31 (compared to the current share price of $57.90). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
Noodles (NDLS) To Report Earnings Tomorrow: Here Is What To Expect
Casual restaurant chain Noodles & Company (NASDAQ:NDLS) will be announcing earnings results this Wednesday afternoon. Here's what to expect. Noodles met analysts' revenue expectations last quarter, reporting revenues of $123.8 million, up 2% year on year. It was a slower quarter for the company, with a significant miss of analysts' EBITDA estimates and a significant miss of analysts' EPS estimates. Is Noodles a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Noodles's revenue to grow 3.5% year on year to $131.9 million, improving from the 1.8% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.06 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Noodles has missed Wall Street's revenue estimates six times over the last two years. Looking at Noodles's peers in the modern fast food segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Shake Shack delivered year-on-year revenue growth of 12.6%, beating analysts' expectations by 0.9%, and Wingstop reported revenues up 12%, topping estimates by 0.5%. Shake Shack traded down 20.7% following the results while Wingstop was up 29.7%. Read our full analysis of Shake Shack's results here and Wingstop's results here. Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the modern fast food stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 6.3% on average over the last month. Noodles is up 14% during the same time and is heading into earnings with an average analyst price target of $2.83 (compared to the current share price of $0.90). Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Earnings To Watch: Allient (ALNT) Reports Q2 Results Tomorrow
Precision motion systems specialist Allient (NASDAQ:ALNT) will be reporting results this Wednesday afternoon. Here's what to expect. Allient beat analysts' revenue expectations by 5.7% last quarter, reporting revenues of $132.8 million, down 9.5% year on year. It was an incredible quarter for the company, with a solid beat of analysts' EPS estimates and an impressive beat of analysts' EBITDA estimates. Is Allient a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Allient's revenue to decline 2.3% year on year to $132.9 million, improving from the 7.3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.47 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Allient has missed Wall Street's revenue estimates twice over the last two years. Looking at Allient's peers in the electronic components segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Bel Fuse delivered year-on-year revenue growth of 26.3%, beating analysts' expectations by 10.1%, and Littelfuse reported revenues up 9.8%, topping estimates by 6.8%. Bel Fuse traded up 18.8% following the results while Littelfuse was also up 9.1%. Read our full analysis of Bel Fuse's results here and Littelfuse's results here. Investors in the electronic components segment have had steady hands going into earnings, with share prices up 1.4% on average over the last month. Allient is up 4.7% during the same time and is heading into earnings with an average analyst price target of $37.33 (compared to the current share price of $39.67). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
